Author： Kaufman Peter A. Bloom Kenneth J. Burris Howard Gralow Julie R. Mayer Musa Pegram Mark Rugo Hope S. Swain Sandra M. Yardley Denise A. Chau Miu Lalla Deepa Yoo Bongin Brammer Melissa G. Vogel Charles L.
Publisher： Blackwell Publishing
E-ISSN： 1097-0142|120|17|2657-2664
ISSN： 0008-543X
Source： Cancer, Vol.120, Iss.17, 2014-09, pp. : 2657-2664
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Lapatinib no help in HER-2-negative breast cancer
Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. :
Access to resources
Recommend
Ixabepilone delivers in ER− and HER2+ breast cancer
Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. :
Trastuzumab tallies up in HER2+ breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. :
Trastuzumab tallies up in HER2+ breast cancer
Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. :